1 Select seq PB208481.1
JP 2020504764-A/21625: mRNA vaccines
synthetic construct
NA
32630
2278
2278
95%
0.0
95.82%
1410
PB208481.1
2 Select seq PB210326.1
JP 2020504764-A/23470: mRNA vaccines
synthetic construct
NA
32630
2272
2272
95%
0.0
95.74%
1410
PB210326.1
3 Select seq PB210323.1
JP 2020504764-A/23467: mRNA vaccines
synthetic construct
NA
32630
2178
2178
95%
0.0
94.54%
1410
PB210323.1
4 Select seq PB210324.1
JP 2020504764-A/23468: mRNA vaccines
synthetic construct
NA
32630
2156
2156
95%
0.0
94.26%
1410
PB210324.1
5 Select seq MM708020.1
Sequence 72 from patent US 10206994
0
1748
1748
99%
0.0
88.30%
1458
MM708020.1
6 Select seq MY866998.1
Sequence 27 from patent US 11253584
0
1742
1742
99%
0.0
88.24%
1458
MY866998.1
7 Select seq MY773176.1
Sequence 27 from patent US 11207399
0
1742
1742
99%
0.0
88.24%
1458
MY773176.1
8 Select seq PA267732.1
JP 2021509818-A/92: USE OF ANP32 PROTEIN IN MAINTAINING INFLUENZA VIRUS POLYMERASE ACTIVITY IN HOST
synthetic construct
NA
32630
1742
1742
99%
0.0
88.24%
1458
PA267732.1
9 Select seq LY979022.1
KR 1020200021100-A/27: Influenza virus mutants and uses therefor
synthetic construct
NA
32630
1742
1742
99%
0.0
88.24%
1458
LY979022.1
10 Select seq MO750871.1
Sequence 85 from patent US 10548967
0
1742
1742
99%
0.0
88.24%
1458
MO750871.1
11 Select seq MO564550.1
Sequence 27 from patent US 10500267
0
1742
1742
99%
0.0
88.24%
1458
MO564550.1
12 Select seq LY610521.1
KR 1020180094147-A/27: Influenza virus mutants and uses therefor
synthetic construct
NA
32630
1742
1742
99%
0.0
88.24%
1458
LY610521.1
13 Select seq LY610493.1
KR 1020180094145-A/27: Influenza virus mutants and uses therefor
synthetic construct
NA
32630
1742
1742
99%
0.0
88.24%
1458
LY610493.1
14 Select seq MA903377.1
JP 2018046851-A/22: INFLUENZA VIRUS MUTANTS AND USES THEREFOR
synthetic construct
NA
32630
1742
1742
99%
0.0
88.24%
1458
MA903377.1
15 Select seq MA903349.1
JP 2018046850-A/22: INFLUENZA VIRUS MUTANTS AND USES THEREFOR
synthetic construct
NA
32630
1742
1742
99%
0.0
88.24%
1458
MA903349.1
16 Select seq MI465716.1
Sequence 27 from patent US 9919043
0
1742
1742
99%
0.0
88.24%
1458
MI465716.1
17 Select seq MI465688.1
Sequence 27 from patent US 9919042
0
1742
1742
99%
0.0
88.24%
1458
MI465688.1
18 Select seq MI065672.1
Sequence 27 from patent US 9757446
0
1742
1742
99%
0.0
88.24%
1458
MI065672.1
19 Select seq MS934680.1
Sequence 27 from Patent EP3119883
synthetic construct
NA
32630
1742
1742
99%
0.0
88.24%
1458
MS934680.1
20 Select seq HL719895.1
Sequence 27 from patent US 9284533
0
1742
1742
99%
0.0
88.24%
1458
HL719895.1
21 Select seq HW764591.1
JP 2014526883-A/22: INFLUENZA VIRUS MUTANTS AND USES THEREFOR
synthetic construct
NA
32630
1742
1742
99%
0.0
88.24%
1458
HW764591.1
22 Select seq HW071460.1
JP 2012531205-A/3: Swine Influenza Hemagglutinin Variants
Haemophilus influenzae
NA
727
1742
1742
99%
0.0
88.24%
1458
HW071460.1
23 Select seq JB147296.1
Sequence 6 from Patent EP2483428
Influenza A virus (H1N1)
NA
1323429
1736
1736
99%
0.0
88.17%
1458
JB147296.1
24 Select seq PB203840.1
JP 2020504764-A/16984: mRNA vaccines
synthetic construct
NA
32630
1707
1707
95%
0.0
88.53%
1410
PB203840.1
25 Select seq PB206671.1
JP 2020504764-A/19815: mRNA vaccines
synthetic construct
NA
32630
1701
1701
95%
0.0
88.46%
1410
PB206671.1
26 Select seq PB210634.1
JP 2020504764-A/23778: mRNA vaccines
synthetic construct
NA
32630
1701
1701
95%
0.0
88.46%
1410
PB210634.1
27 Select seq PB207843.1
JP 2020504764-A/20987: mRNA vaccines
synthetic construct
NA
32630
1701
1701
95%
0.0
88.46%
1410
PB207843.1
28 Select seq PB209327.1
JP 2020504764-A/22471: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB209327.1
29 Select seq PB204404.1
JP 2020504764-A/17548: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB204404.1
30 Select seq PB204398.1
JP 2020504764-A/17542: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB204398.1
31 Select seq PB204229.1
JP 2020504764-A/17373: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB204229.1
32 Select seq PB210631.1
JP 2020504764-A/23775: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB210631.1
33 Select seq PB210622.1
JP 2020504764-A/23766: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB210622.1
34 Select seq PB210088.1
JP 2020504764-A/23232: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB210088.1
35 Select seq PB208193.1
JP 2020504764-A/21337: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.38%
1410
PB208193.1
36 Select seq PB208235.1
JP 2020504764-A/21379: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB208235.1
37 Select seq PB206426.1
JP 2020504764-A/19570: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB206426.1
38 Select seq PB206418.1
JP 2020504764-A/19562: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB206418.1
39 Select seq PB205491.1
JP 2020504764-A/18635: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB205491.1
40 Select seq PB203973.1
JP 2020504764-A/17117: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB203973.1
41 Select seq PB203912.1
JP 2020504764-A/17056: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB203912.1
42 Select seq PB203740.1
JP 2020504764-A/16884: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB203740.1
43 Select seq PB203628.1
JP 2020504764-A/16772: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB203628.1
44 Select seq PB203615.1
JP 2020504764-A/16759: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB203615.1
45 Select seq PB203614.1
JP 2020504764-A/16758: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB203614.1
46 Select seq PB203605.1
JP 2020504764-A/16749: mRNA vaccines
synthetic construct
NA
32630
1696
1696
95%
0.0
88.39%
1410
PB203605.1
47 Select seq PB212775.1
JP 2020504764-A/25919: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB212775.1
48 Select seq PB210615.1
JP 2020504764-A/23759: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB210615.1
49 Select seq PB209271.1
JP 2020504764-A/22415: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB209271.1
50 Select seq PB209259.1
JP 2020504764-A/22403: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB209259.1
51 Select seq PB207477.1
JP 2020504764-A/20621: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB207477.1
52 Select seq PB206666.1
JP 2020504764-A/19810: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB206666.1
53 Select seq PB205986.1
JP 2020504764-A/19130: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB205986.1
54 Select seq PB205384.1
JP 2020504764-A/18528: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB205384.1
55 Select seq PB204405.1
JP 2020504764-A/17549: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204405.1
56 Select seq PB204402.1
JP 2020504764-A/17546: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204402.1
57 Select seq PB204371.1
JP 2020504764-A/17515: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204371.1
58 Select seq PB204331.1
JP 2020504764-A/17475: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204331.1
59 Select seq PB204293.1
JP 2020504764-A/17437: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204293.1
60 Select seq PB204279.1
JP 2020504764-A/17423: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204279.1
61 Select seq PB204240.1
JP 2020504764-A/17384: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204240.1
62 Select seq PB210637.1
JP 2020504764-A/23781: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB210637.1
63 Select seq PB210629.1
JP 2020504764-A/23773: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB210629.1
64 Select seq PB210096.1
JP 2020504764-A/23240: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB210096.1
65 Select seq PB208104.1
JP 2020504764-A/21248: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB208104.1
66 Select seq PB208097.1
JP 2020504764-A/21241: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB208097.1
67 Select seq PB205626.1
JP 2020504764-A/18770: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB205626.1
68 Select seq PB205976.1
JP 2020504764-A/19120: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB205976.1
69 Select seq PB205321.1
JP 2020504764-A/18465: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB205321.1
70 Select seq PB204966.1
JP 2020504764-A/18110: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204966.1
71 Select seq PB204962.1
JP 2020504764-A/18106: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204962.1
72 Select seq PB208290.1
JP 2020504764-A/21434: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB208290.1
73 Select seq PB209611.1
JP 2020504764-A/22755: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB209611.1
74 Select seq PB209696.1
JP 2020504764-A/22840: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB209696.1
75 Select seq PB209671.1
JP 2020504764-A/22815: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB209671.1
76 Select seq PB207660.1
JP 2020504764-A/20804: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB207660.1
77 Select seq PB207291.1
JP 2020504764-A/20435: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB207291.1
78 Select seq PB207197.1
JP 2020504764-A/20341: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB207197.1
79 Select seq PB207191.1
JP 2020504764-A/20335: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB207191.1
80 Select seq PB206990.1
JP 2020504764-A/20134: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB206990.1
81 Select seq PB206947.1
JP 2020504764-A/20091: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB206947.1
82 Select seq PB206538.1
JP 2020504764-A/19682: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB206538.1
83 Select seq PB206533.1
JP 2020504764-A/19677: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB206533.1
84 Select seq PB206451.1
JP 2020504764-A/19595: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB206451.1
85 Select seq PB206419.1
JP 2020504764-A/19563: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB206419.1
86 Select seq PB206270.1
JP 2020504764-A/19414: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB206270.1
87 Select seq PB204163.1
JP 2020504764-A/17307: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204163.1
88 Select seq PB205236.1
JP 2020504764-A/18380: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB205236.1
89 Select seq PB205939.1
JP 2020504764-A/19083: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB205939.1
90 Select seq PB205886.1
JP 2020504764-A/19030: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB205886.1
91 Select seq PB205867.1
JP 2020504764-A/19011: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB205867.1
92 Select seq PB205824.1
JP 2020504764-A/18968: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB205824.1
93 Select seq PB205507.1
JP 2020504764-A/18651: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB205507.1
94 Select seq PB205485.1
JP 2020504764-A/18629: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB205485.1
95 Select seq PB204792.1
JP 2020504764-A/17936: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.32%
1410
PB204792.1
96 Select seq PB204788.1
JP 2020504764-A/17932: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204788.1
97 Select seq PB204702.1
JP 2020504764-A/17846: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204702.1
98 Select seq PB204543.1
JP 2020504764-A/17687: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204543.1
99 Select seq PB204514.1
JP 2020504764-A/17658: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204514.1
100 Select seq PB204511.1
JP 2020504764-A/17655: mRNA vaccines
synthetic construct
NA
32630
1690
1690
95%
0.0
88.31%
1410
PB204511.1